rs137852357
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000132.4(F8):c.6496C>T(p.Arg2166*) variant causes a stop gained change. The variant allele was found at a frequency of 0.000000913 in 1,095,245 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000132.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
F8 | ENST00000360256.9 | c.6496C>T | p.Arg2166* | stop_gained | Exon 23 of 26 | 1 | NM_000132.4 | ENSP00000353393.4 | ||
F8 | ENST00000330287.10 | c.91C>T | p.Arg31* | stop_gained | Exon 2 of 5 | 1 | ENSP00000327895.6 | |||
F8 | ENST00000644698.1 | c.229C>T | p.Arg77* | stop_gained | Exon 3 of 6 | ENSP00000495706.1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome AF: 9.13e-7 AC: 1AN: 1095245Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 360657
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Hereditary factor VIII deficiency disease Pathogenic:3
The F8 c.6496C>T; p.Arg2166Ter variant (rs137852357), also known as Arg2147Ter, is reported in the literature in several individuals affected with severe hemophilia A (see link to FVIII database and references therein, Feng 2021, Kang 2021, Villarreal-Martinez 2020). This variant is also reported in ClinVar (Variation ID: 10096), but is absent from the Genome Aggregation Database, indicating it is not a common polymorphism. This variant induces an early termination codon and is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Based on available information, this variant is considered to be pathogenic. References: Link to FVIII database: https://f8-db.eahad.org Feng Y et al. Mutation analysis in the F8 gene in 485 families with haemophilia A and prenatal diagnosis in China. Haemophilia. 2021 Jan;27(1):e88-e92PMID: 33245802. Kang H et al. FVIII inhibitor risk correlated with F8 gene variants in 296 unrelated male Chinese patients with haemophilia A. Haemophilia. 2021 Mar;27(2):e274-e277. PMID: 32897612. Villarreal-Martinez L et al. Molecular genetic diagnosis by next-generation sequencing in a cohort of Mexican patients with haemophilia and report of novel variants. Blood Cells Mol Dis. 2020 Jul;83:102423. PMID: 32224444. -
- -
Variant summary: F8 c.6496C>T (p.Arg2166X) results in a premature termination codon, predicted to cause absence of the protein due to nonsense mediated decay, which is a commonly known mechanism for disease. The variant was absent in 183368 control chromosomes. c.6496C>T has been reported in the literature in at-least one individual affected with Factor VIII Deficiency (Hemophilia A) (example, Youssoufian_1988). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 2833855). ClinVar contains an entry for this variant (Variation ID: 10096). Based on the evidence outlined above, the variant was classified as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at